Ankit Alok Bagaria (Loopworm): 10 Key Things You Must Know
Overview
Ankit Alok Bagaria is an influential figure in the biotech industry, most notably recognized for his role as the co-founder and CEO of Loopworm. Loopworm is a groundbreaking startup harnessing the power of biotechnology to produce sustainable insect-derived products. Bagaria's innovative approach centers around utilizing silkworms as mini bioreactors to produce recombinant proteins. Under his leadership, Loopworm has already begun revolutionizing the feed industry by providing an alternative source of protein that is cost-effective and environmentally friendly. As this article will unfold, Ankit's journey is not only marked by entrepreneurial success but also by his commitment to solving pressing global challenges through sustainable practices.
1. Ankit's Academic Foundation
Ankit Alok Bagaria's academic pursuits laid the groundwork for his future endeavors. He graduated with a Dual Degree in Chemical Engineering from the prestigious Indian Institute of Technology (IIT) Roorkee. It was during his time at IIT that Bagaria's interest in sustainable solutions was piqued, particularly influenced by a United Nations report declaring "Insects are the Future of Food & Feed." His academic background in chemical engineering provided him with a robust foundation for understanding the complex intersection of biology and technology, which would later become the focus of his entrepreneurial efforts.
2. Founding of Loopworm
In 2019, Ankit co-founded Loopworm alongside Abhi Gawri. The venture was established with a mission to disrupt the conventional protein supply chain by introducing insect-derived proteins as a sustainable alternative. Loopworm leverages the natural capabilities of silkworms to produce high-value proteins and fats for various industries. The company quickly gained attention for its innovative approach to sustainability and biotechnology, which involves using insects as living biofactories, bypassing the need for expensive and energy-intensive bioreactors.
3. Innovative Approaches in Biotechnology
Loopworm's approach to biotechnology involves using silkworms and black soldier flies to produce complex proteins. This method is not only cost-effective but also lowers environmental impact. Silkworms are utilized to express recombinant proteins, which are essential in various applications such as diagnostics, animal vaccines, and even human wellness products. This innovative method has drastically changed the economics of protein manufacturing, offering a cheaper and faster alternative to traditional methods.
4. Impact on Sustainable Practices
Under Bagaria’s leadership, Loopworm has made significant strides in promoting sustainable practices. The company's production process requires significantly less water and land compared to traditional protein sources. By turning food waste into a valuable resource, Loopworm contributes to a circular economy. Their products are increasingly being used in the aquaculture and pet food industries, providing a sustainable feed option that does not deplete natural resources.
5. Funding and Growth
Loopworm has successfully raised impressive funding to support its mission. As of 2025, the company has secured $6.65 million in funding. Notably, their rounds have been backed by notable venture capital firms like WaterBridge Ventures and Omnivore. This financial backing has been vital in facilitating Loopworm's research and development initiatives, expanding their production capacities, and scaling up their operations to meet growing global demand for sustainable proteins.
6. Patented Technologies and Processes
Ankit has played a pivotal role in securing Loopworm's intellectual property, with the company having filed multiple patents related to their protein production technology. These patents fortify Loopworm's position in the biotech industry, ensuring their unique methods of using silkworms to produce proteins remain proprietary and protected, allowing the company to maintain a competitive edge.
7. Collaborations and Partnerships
Loopworm thrives on strategic collaborations and partnership agreements. By aligning with research institutions, corporate partners, and even government bodies, the company is well-positioned to enhance its technology and expand its market reach. These partnerships also include collaborations for R&D initiatives and exploring new applications for their technologies.
8. Recognition and Awards
Ankit Alok Bagaria’s work with Loopworm has earned him considerable recognition. He was listed on Forbes India's 30 Under 30 in 2024, underscoring his impact in the industry. His leadership and innovative strategies in promoting sustainability and biotechnology have garnered accolades, solidifying his reputation as a visionary in the biotech community.
9. Future Prospects
As Loopworm continues to grow, the company aims to significantly increase its production of insect-derived proteins, targeting 300,000 metric tons annually within the next five years. This ambitious goal is aligned with Bagaria’s vision to strengthen India’s position in the global biotech economy. The company is also exploring new market opportunities in sectors such as cosmetics and pharmaceuticals.
10. Addressing Global Challenges
Ankit Alok Bagaria remains committed to addressing global challenges through his work with Loopworm. By focusing on sustainable and scalable solutions, he aims to contribute to global food security and reduce environmental impact. His efforts are particularly pertinent in the face of climate change and resource scarcity, positioning Loopworm as a crucial player in the conversation about sustainable food production.
Conclusion
Ankit Alok Bagaria's journey with Loopworm is a testament to the power of innovation and sustainable thinking in addressing global challenges. His ability to marry biotechnology with sustainability principles is revolutionizing the feed industry. As Loopworm continues to expand, Ankit's vision for a greener, more sustainable world appears ever closer to reality. His work not only marks a significant contribution to biotechnology but also highlights the potential for startups to drive global change.